Laboratory News and Research

RSS

Interaction between PTSD and klotho gene may cause premature aging in the brain

Study Finds PTSD Interacts With Klotho Gene, May Cause Premature Aging In The Brain

27 Oct 2020

Study finds new transposon-derived genes related to autism

The lack of some genes in the BEC/TCEAL cluster could be related to some alterations associated with the autism spectrum disorder, according to a preclinical study published in the journal Genome Biology, and led by Professor Jordi Garcia Fernàndez, from the Faculty of Biology and the Institute of Biomedicine of the University of Barcelona, and researcher Jaime Carvajal, from the Andalusian Centre for Developmental Biology - University Pablo de Olavide.

27 Oct 2020

Genome-wide screens reveal new helpful and harmful COVID-19 related genes

Researchers at Yale University and the Broad Institute of MIT and Harvard screened hundreds of millions of cells exposed to the COVID-19 and MERS viruses and identified dozens of genes that both enable the viruses to replicate in cells and also those that seem to slam the door on the virus.

27 Oct 2020

Researchers develop low-cost, customizable, self-locking upper limb prosthesis

Upper limb forequarter amputations which involve the removal of the entire arm and scapula require highly customized prosthetic devices that are expensive but yet, usually underutilized due to their high maintenance and low comfort levels.

27 Oct 2020

COVID-19 antibiotic risk factors

Now, a team of researchers at the University of Rochester Medical Center aimed to determine antibiotic prescribing rates and risk factors for antibiotic prescribing in hospitalized patients. They found that almost one-third of patients received more than one course of antibiotics.

27 Oct 2020

EKF launches PrimeStore® MTM pathogenic sample collection and transportation kit

EKF Diagnostics, the global in-vitro diagnostics company, announces that it has launched a PrimeStore® MTM sample collection kit.

From EKF Diagnostics 26 Oct 2020

Scientists devise new method to map HIV's sugary shield in unprecedented detail

Scientists from Scripps Research and Los Alamos National Laboratory have devised a method for mapping in unprecedented detail the thickets of slippery sugar molecules that help shield HIV from the immune system.

23 Oct 2020

Age can affect response to adjuvant treatment among patients with resected melanoma

Younger patients with resected melanoma had some benefit from adjuvant treatment with the anti-VEGF therapeutic bevacizumab (Avastin) while older patients with resected melanoma did not

23 Oct 2020

Bioplastics are just as toxic as other plastics

Conventional plastic is made from oil. The production of plastic is not sustainable, and it can contain substances we know are dangerous if ingested.

23 Oct 2020

Oral bacteria persist on wasted chewing gums for weeks

Researchers from the Institute of Integrative Systems Biology (I2SysBio), a joint center of the University of Valencia and the CSIC, have analyzed the bacteria from used chewing gums from five different countries.

23 Oct 2020

Initial phase of COVID-19 lockdown decreased sleep, exercise and mental health

A first-of-its-kind global survey shows the initial phase of the COVID-19 lockdown dramatically altered our personal habits, largely for the worse.

23 Oct 2020

New technique could propel personalized cancer treatments

When it comes to defeating cancer, some immune cells are mightier than others. But even the best-trained eye and today's advanced scientific tools have trouble discerning the most powerful tumor-fighting cells from the rest.

23 Oct 2020

AFAR receives renewal award from NIA to pursue research into the biology of aging

The American Federation for Aging Research (AFAR), has received a renewal award for up to $2 million over five years from the National Institute on Aging (NIA) to continue its role as the Nathan Shock Centers for Excellence in the Biology of Aging Coordinating Center (NSCs).

23 Oct 2020

Researchers create AI system that matches tumors to best drug combinations

Only 4 percent of all cancer therapeutic drugs under development earn final approval by the U.S. Food and Drug Administration (FDA).

23 Oct 2020

EPA administrator receives PETA research grant

For preventing countless animals from being used in chemical tests, U.S. Environmental Protection Agency (EPA) Administrator Andrew Wheeler is being honored by the creation of the Pat C. Wheeler Scholarship--a tribute to his late mother, a lifelong advocate for the humane treatment of all animals.

23 Oct 2020

New therapeutic approach for treating patients with compromised immune systems

A young woman who had been hospitalized for three months straight due to debilitating, recurrent infections with no apparent underlying cause was finally able to go home thanks to a Massachusetts General Hospital (MGH) team who put their heads together, discovered a root of the problem, and developed a novel treatment strategy just for her.

23 Oct 2020

Dexamethasone drug may not benefit COVID-19 patients with diabetes or low albumin levels

A new discovery about how the body transports dexamethasone, a drug that can increase the survival chances of patients with severe COVID-19, suggests diabetes and other factors may reduce its potentially lifesaving effectiveness.

23 Oct 2020

Researchers use viral signatures to reveal transmission patterns of SARS-CoV-2

The coronavirus, responsible for the COVID-19 pandemic, has one official name--SARS-CoV-2. But according to virologists, mutations lead to hundreds of genetically-distinct versions of the virus.

23 Oct 2020

Study raises new questions about viral load in asymptomatic children with COVID-19

New questions are at the forefront as a study published in the Journal of Clinical Microbiology from nine children's hospitals finds that most asymptomatic children who tested positive for COVID-19 had relatively low levels of the virus compared to symptomatic children.

22 Oct 2020

Navy researchers evaluate commercial UV sources for viral disinfection to combat COVID-19

U.S. Naval Research Laboratory researchers evaluated commercial ultraviolet (UV) sources for viral disinfection to combat COVID-19 on land and at sea, and established a dedicated UV characterization lab in five days to ensure safe introduction and effective operation of UV sources across the Fleet.

22 Oct 2020